1
|
Peck RC, Knapp-Wilson A, Burley K, Dorée C, Griffin J, Mumford AD, Stanworth S, Sharplin K. Scoping review of factors associated with stem cell mobilization and collection in allogeneic stem cell donors. Transplant Cell Ther 2024:S2666-6367(24)00439-1. [PMID: 38851322 DOI: 10.1016/j.jtct.2024.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2024] [Revised: 05/30/2024] [Accepted: 06/01/2024] [Indexed: 06/10/2024]
Abstract
BACKGROUND There is a large inter-individual variation in the efficacy of CD34+ cell mobilization and collection in healthy allogenic hematopoietic stem cell donors. Donor characteristics, blood cell counts, and factors related to mobilization and collection have previously been associated with blood CD34+ cell count or CD34+ cell yield after G-CSF mobilization and collection. Since the literature reporting associations is heterogeneous, we clarify the determinants of CD34+ count and yield in a scoping review. MATERIALS AND METHODS Studies published between 2000 and 2023 were evaluated if they reported allogeneic donors undergoing G-CSF mobilization and peripheral blood stem cell collection (PBSC). Eligible studies assessed blood CD34+ cell count or CD34+ cell yield in the first PBSC collection after mobilization with 4 or 5 days of G-CSF treatment. Associations were recorded between these outcomes and donor factors (age, gender, weight, ethnicity), mobilization factors (G-CSF scheduling or dose), collection factors (venous access, processed blood volume) or laboratory factors (blood cell counts at baseline or after mobilization). RESULTS The 52 studies each evaluated between 15 and 20,884 donors. 43 studies were retrospective, 33 assessed blood CD34+ cell counts and 39 assessed CD34+ cell yield from PBSC. Blood CD34+ cell counts consistently predicted CD34+ cell yield. Younger donors usually had higher blood CD34+ cell counts and CD34+ cell yield. Most studies that investigated the effect of donor ancestry found that non-European ancestry donors had higher blood CD34+ cell counts after mobilization and CD34+ cell yields from collection. CONCLUSIONS There remains poor consensus about the best predictors of blood CD34+ cell counts and yield that requires further prospective study, particularly of the role of donor ancestry. The current focus on donor gender as a major predictor requires re-evaluation.
Collapse
Affiliation(s)
- Rachel C Peck
- NHS Blood and Transplant, Bristol, UK; Faculty of Life Sciences, University of Bristol, Bristol, UK.
| | | | - Kate Burley
- Faculty of Life Sciences, University of Bristol, Bristol, UK
| | - Carolyn Dorée
- Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK
| | | | | | - Simon Stanworth
- NHS Blood and Transplant, Bristol, UK; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - Kirsty Sharplin
- NHS Blood and Transplant, Bristol, UK; University of Sydney, Australia
| |
Collapse
|
2
|
Pınar İE, Özkocaman V, Özkalemkaş F, Durgut H, Dakiki B, Ersal T, Gürsoy V, Yalçın C, Orhan B, Candar Ö, Ali R. Is split-dose better than single-dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G-CSF. J Clin Apher 2022; 37:430-437. [PMID: 35689647 DOI: 10.1002/jca.21995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 05/12/2022] [Accepted: 05/16/2022] [Indexed: 11/07/2022]
Abstract
BACKGROUND Turkish Stem Cell Coordination Center (TURKOK) carries out the procurement process of unrelated allogeneic hematopoietic stem cells in Turkey. This study aims to compare the efficacy of both once-daily and divided-dose G-CSF administration and the original and biosimilar G-CSF use and the frequency and severity of adverse events in TURKOK donors. METHOD The study was conducted retrospectively with 142 healthy TURKOK donors. For PBSC mobilization, two different subcutaneous G-CSF programs were used as 10 μ/kg/day single-dose and 5 μ/kg/12 h. Neupogen (Amgen, Puerto Rico) and Tevagrastim (Teva, Kfar Saba, Israel) were used as G-CSF. All donors started apheresis on the fifth day, and all side effects were recorded during the procedure. RESULTS Stem cell yield was similar between single-dose and divided-doses based on donor weight, favoring the split-dose based on recipient weight (P = .506 and P = .023, respectively). Both G-CSF posologies were comparable if the target CD34+ cell yield was ≥4 × 106 /kg. CD34+ cell yield was equivalent when evaluated against recipient weight, significantly favoring Tevagrastim vs Neupogen by donor weight (P = .740 and P = .021, respectively). Side effects, duration of pain, and need for analgesia favor Tevagratim over Neupogen. CONCLUSION Split-dose may be recommended for cases where the need for large numbers of CD34+ cells to be harvested is anticipated due to significant cell yield relative to recipient weight. However, sufficient hematopoietic stem cells can be collected with both posology. Tevagrastim is non-inferiority effective to Neupogen. Side effects during administration are both low-grade and temporary.
Collapse
Affiliation(s)
- İbrahim Ethem Pınar
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Vildan Özkocaman
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Fahir Özkalemkaş
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Himmet Durgut
- Republic of Turkey Ministry of Health, Turkish Stem Cell Coordination Center, Ankara, Turkey
| | - Bahar Dakiki
- Department of Internal Medicine, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Tuba Ersal
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Vildan Gürsoy
- Department of Internal Medicine, Division of Hematology, Bursa City Hospital, Bursa, Turkey
| | - Cumali Yalçın
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Bedrettin Orhan
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Ömer Candar
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| | - Rıdvan Ali
- Department of Internal Medicine, Division of Hematology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey
| |
Collapse
|
3
|
Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients. Bone Marrow Transplant 2022; 57:729-733. [PMID: 35190673 PMCID: PMC9090625 DOI: 10.1038/s41409-022-01614-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Revised: 02/03/2022] [Accepted: 02/08/2022] [Indexed: 11/08/2022]
Abstract
High-dose chemotherapy (HD-Cx) in refractory germ cell cancer (GCC) is effective but limited data are available concerning the optimal approach for stem cell mobilization (SCM) in these patients. In this analysis 102 patients undergoing SCM during first (n = 25) or subsequent treatment lines (n = 77) were analyzed. Subcutaneous injections of granulocyte colony-stimulating factor (G-CSF) were given once daily (group 1) in 52 patients (51%), twice daily (group 2) in 39 patients (38%) or one injection Pegylated-G-CSF (PegG-CSF) (group 3) in eleven patients (11%) after one cycle of mobilization chemotherapy. Plerixafor was administered 13 times in group 1, seven times in group 2 and once in group 3. Overall, 77 (75%) patients achieved successful SCM defined as ≥8*106 CD34+ cells/kg body weight for three consecutive HD-Cx plus one backup dose. In group 1, 40 of 52 patients (77%) achieved successful SCM with a median of 11 G-CSF injections, in group 2, 27 of 39 patients (69%) with a median of 14 G-CSF injections and in group 3, 10 of 11 patients (91%) with one injection of PegG-CSF. SCM was more successful if conducted during first-line chemotherapy (p = 0.016) and associated with a beneficial outcome concerning overall survival (p = 0.02) if performed satisfactorily.
Collapse
|
4
|
Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma. Bone Marrow Transplant 2018. [DOI: 10.1038/s41409-018-0152-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
5
|
Shin S, Kim J, Kim-Wanner SZ, Bönig H, Cho SR, Kim S, Choi JR, Lee KA. A novel association between relaxin receptor polymorphism and hematopoietic stem cell yield after mobilization. PLoS One 2017; 12:e0179986. [PMID: 28666004 PMCID: PMC5493337 DOI: 10.1371/journal.pone.0179986] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2017] [Accepted: 06/07/2017] [Indexed: 11/19/2022] Open
Abstract
Mobilization of hematopoietic stem cells (HSCs) from the bone marrow to the peripheral blood is a complex mechanism that involves adhesive and chemotactic interactions of HSCs as well as their bone marrow microenvironment. In addition to a number of non-genetic factors, genetic susceptibilities also contribute to the mobilization outcome. Identification of genetic factors associated with HSC yield is important to better understand the mechanism behind HSC mobilization. In the present study, we enrolled 148 Korean participants (56 healthy donors and 92 patients) undergoing HSC mobilization for allogeneic or autologous HSC transplantation. Among a total of 53 polymorphisms in 33 candidate genes, one polymorphism (rs11264422) in relaxin/insulin-like family peptide receptor 4 (RXFP4) gene was significantly associated with a higher HSC yield after mobilization in Koreans. However, in a set of 101 Europeans, no association was found between circulating CD34+ cell counts and rs11264422 genotype. Therefore, we suggest that the ethnic differences in subjects’ genetic background may be related to HSC mobilization. In conclusion, the relaxin—relaxin receptor axis may play an important role in HSC mobilization. We believe that the results of the current study could provide new insights for therapies that use relaxin and HSC populations, as well as a better understanding of HSC regulation and mobilization at the molecular level.
Collapse
Affiliation(s)
- Saeam Shin
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
- Department of Laboratory Medicine, Hallym University College of Medicine, Kangnam Sacred Heart Hospital, Seoul, Korea
| | - Juwon Kim
- Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
| | | | - Halvard Bönig
- German Red Cross Blood Service BaWüHe, Frankfurt, Germany
- Institute for Transfusion Medicine and Immune Hematology of the Johann-Wolfgang-Goethe Medical University, Frankfurt, Germany
- Department of Medicine/Hematology, University of Washington, Seattle, Washington, United States of America
| | - Sung Ran Cho
- Department of Laboratory Medicine, Ajou University School of Medicine, Suwon, Korea
| | - Sinyoung Kim
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - Jong Rak Choi
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - Kyung-A Lee
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
- * E-mail:
| |
Collapse
|
6
|
Machaczka M, Hägglund H, Staver E, Joks M, Hassan M, Wahlin BE, Axdorph Nygell U. G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield. J Clin Apher 2017; 32:384-391. [DOI: 10.1002/jca.21524] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2016] [Revised: 12/16/2016] [Accepted: 12/19/2016] [Indexed: 11/06/2022]
Affiliation(s)
- Maciej Machaczka
- Department of Medicine at Huddinge; Karolinska Institutet and Hematology Center Karolinska, Karolinska University Hospital; Stockholm Sweden
| | - Hans Hägglund
- Department of Medicine at Huddinge; Karolinska Institutet and Hematology Center Karolinska, Karolinska University Hospital; Stockholm Sweden
- Department of Medical Sciences; Hematology, Uppsala University; Uppsala Sweden
| | - Emma Staver
- Department of Medicine at Huddinge; Karolinska Institutet and Hematology Center Karolinska, Karolinska University Hospital; Stockholm Sweden
| | - Monika Joks
- Department of Hematology and Bone Marrow Transplantation; Poznan University of Medical Sciences; Poznan Poland
| | - Moustapha Hassan
- Experimental Cancer Medicine; Clinical Research Centre, Department of Laboratory Medicine, Karolinska Institutet and Department of Clinical Research Centre, Karolinska University Hospital; Stockholm Sweden
| | - Björn Engelbrekt Wahlin
- Department of Medicine at Huddinge; Karolinska Institutet and Hematology Center Karolinska, Karolinska University Hospital; Stockholm Sweden
| | - Ulla Axdorph Nygell
- Department of Medicine at Huddinge; Karolinska Institutet and Hematology Center Karolinska, Karolinska University Hospital; Stockholm Sweden
- Department of Oncology and Pathology; Karolinska Institutet and Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital; Stockholm Sweden
| |
Collapse
|
7
|
Martino M, Moscato T, Barillà S, Dattola A, Pontari A, Fedele R, Furlò G, Marzia Stilo C, Alberto Gallo G, Tripepi G. Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control. Transfusion 2015; 55:2032-8. [DOI: 10.1111/trf.13117] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2014] [Revised: 02/13/2015] [Accepted: 02/16/2015] [Indexed: 12/16/2022]
Affiliation(s)
- Massimo Martino
- Hematology and Stem Cells Transplantation Unit, CTMO; CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Tiziana Moscato
- Hematology and Stem Cells Transplantation Unit, CTMO; CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Santina Barillà
- Hematology and Stem Cells Transplantation Unit, CTMO; CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Antonia Dattola
- Hematology and Stem Cells Transplantation Unit, CTMO; CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Antonella Pontari
- Hematology and Stem Cells Transplantation Unit, CTMO; CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Roberta Fedele
- Hematology and Stem Cells Transplantation Unit, CTMO; CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Giuseppe Furlò
- Immuno-Hematology and Transfusion Medicine; Azienda Ospedaliera “BMM”, CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Carmen Marzia Stilo
- Immuno-Hematology and Transfusion Medicine; Azienda Ospedaliera “BMM”, CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Giuseppe Alberto Gallo
- Hematology and Stem Cells Transplantation Unit, CTMO; CRN Institute of Clinical Physiology; Reggio Calabria Italy
| | - Giovanni Tripepi
- National Research Council (CRN); CRN Institute of Clinical Physiology; Reggio Calabria Italy
| |
Collapse
|
8
|
Kawamura K, Kikuchi M, Terasako K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Kimura SI, Nakasone H, Okuda S, Yamazaki R, Kanda J, Kako S, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. Transfus Apher Sci 2013; 49:334-40. [DOI: 10.1016/j.transci.2013.06.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2013] [Revised: 05/20/2013] [Accepted: 06/04/2013] [Indexed: 10/26/2022]
|
9
|
Namba N, Matsuo K, Kubonishi S, Kikuchi T, Maeda Y, Niiya M, Shinagawa K, Koide N, Ikeda K, Tanimoto M. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells. Transfusion 2009; 49:2384-9. [DOI: 10.1111/j.1537-2995.2009.02314.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|